Bär & Karrer Advised the Helsinn Group on its Financing Agreement with Oberland Capital Management
Bär & Karrer advised the Helsinn Group on its financing agreement with Oberland Capital Management LLC. The Helsinn Group is a fully integrated, global biopharma group with a track record of over 40 years of commercial execution and a strong focus in oncology and rare diseases.
Bär & Karrer acted as Swiss legal advisor to the Helsinn Group in this transaction. The team was led by Paolo Bottini (Corporate / M&A and Tax) and Andrea Ziswiler (Corporate / M&A and Banking, Insurance & Finance), as well as Susanne Schreiber, Elena Kumashova, Michel Morelato and Aron Liechti (all Tax).